Zusammenfassung
Die weltweite Diabetesprävalanz nimmt deutlich zu, wobei es eine hohe Dunkelziffer von Patienten gibt, deren Diabetes noch nicht diagnostiziert wurde. Der folgende Artikel beinhaltet die auf der derzeitigen Evidenzlage basierenden Empfehlungen der Österreichischen Diabetesgesellschaft für Screening und Prävention von Typ 2 Diabetes mellitus.
Summary
The prevalence of diabetes is increasing in westernized countries. In addition, about half of all patients suffering from diabetes are not diagnosed. The current article represents the recommendations of the Austrian Diabetes Association for the screening and prevention of type 2 diabetes, based on currently available evidence.
Literatur
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782–7.
Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003;46:182–9.
Rendell M, Kimmel DB, Bamisedun O, O’Donnell ET, Fulmer J. The health care status of the diabetic population as reflected by physician claims to a major insurer. Arch Intern Med. 1993;153:1360–6.
Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care. 1999;22:1262–5.
Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Suppl 1):S11–63.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
Author information
Authors and Affiliations
Corresponding author
Additional information
Für den Ausschuss Leitlinien
Rights and permissions
About this article
Cite this article
Stadler, M., Prager, R. Typ 2 Diabetes Mellitus – Screening und Prävention. Wien Klin Wochenschr 124 (Suppl 2), 4–6 (2012). https://doi.org/10.1007/s00508-012-0271-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-012-0271-5